Koh, C., Canini, L., Dahari, H., Zhao, X., Uprichard, S. L., Haynes-Williams, V., . . . Heller, T. (2015). Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: A proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial. Lancet Infect Dis.
Citação norma ChicagoKoh, Christopher, et al. "Oral Prenylation Inhibition With Lonafarnib in Chronic Hepatitis D Infection: A Proof-of-concept Randomised, Double-blind, Placebo-controlled Phase 2A Trial." Lancet Infect Dis 2015.
Citação norma MLAKoh, Christopher, et al. "Oral Prenylation Inhibition With Lonafarnib in Chronic Hepatitis D Infection: A Proof-of-concept Randomised, Double-blind, Placebo-controlled Phase 2A Trial." Lancet Infect Dis 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.